SLC19A3 and Thiamine deficiency: Although it is uncertain if fedratinib causes Wernicke’s encephalopathy, these trials highlight the potential for drug–nutrient interaction and questions if potent THTR2 inhibitors are a safety concern for drug-induced localized deficiency especially for populations at risk for thiamine deficiency.